Evidence map›Paper›PMID 27681624›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

MiR-155-regulated molecular network orchestrates cell fate in the innate and adaptive immune response to Mycobacterium tuberculosis.

Alissa C Rothchild, James R Sissons, Shahin Shafiani, Christopher Plaisier, Deborah Min, Dat Mai, Mark Gilchrist, Jacques Peschon, Ryan P Larson, Andreas Bergthaler and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 1 synthesis or guideline pooled it, 129 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Host-directed microRNA-based intervention against intracellularFrontiers in cellular and infection microbiology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Alissa C RothchildCenter for Infectious Disease Research, Seattle, WA 98109.
James R SissonsCenter for Infectious Disease Research, Seattle, WA 98109.
Shahin ShafianiCenter for Infectious Disease Research, Seattle, WA 98109.
Christopher PlaisierInstitute for Systems Biology, Seattle, WA 98109.
Deborah MinCenter for Infectious Disease Research, Seattle, WA 98109.
Dat MaiCenter for Infectious Disease Research, Seattle, WA 98109.
Mark GilchristCenter for Infectious Disease Research, Seattle, WA 98109.
Jacques PeschonNovo Nordisk Inflammation Research Center, Seattle, WA 98109.
Ryan P LarsonCenter for Infectious Disease Research, Seattle, WA 98109.
Andreas BergthalerCeMM Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna 1090, Austria.
Nitin S BaligaInstitute for Systems Biology, Seattle, WA 98109.
Kevin B UrdahlCenter for Infectious Disease Research, Seattle, WA 98109.
Alan AderemCenter for Infectious Disease Research, Seattle, WA 98109; alan.aderem@cidresearch.org.
Infectious Disease Research Institute · USCenter for Infectious Disease Research · USInstitute for Systems Biology · USCeMM Research Center for Molecular Medicine · ATNovo Nordisk (United States) · US

Funding

Systems Biology CoreU19AI100627 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ULEVITCH, RICHARD J · 2012 to 2021
$49.1M
Technology CoreU19AI106761 · NIAID · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI SHERMAN, DAVID R, ZAK, DANIEL E · 2013 to 2017
$18.9M
LPS Signaling in Macrophages: The Roll of TollR01AI032972 · NIAID · UNIVERSITY OF WASHINGTON · PI ADEREM, ALAN A · 1992 to 2020
$14.6M
LPS REGULATION OF MACROPHAGE FUNCTIONR01AI025032 · NIAID · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI ADEREM, ALAN A · 1987 to 2016
$6.7M
T regulatory cells and immunity in tuberculosisR01AI076327 · NIAID · UNIVERSITY OF WASHINGTON · PI URDAHL, KEVIN B · 2009 to 2018
$4.5M
NIAID NIH HHS HHSN272201300006CNIAID NIH HHS R01 AI025032NIAID NIH HHS R01 AI032972NIAID NIH HHS R01 AI076327NIAID NIH HHS U19 AI100627NIAID NIH HHS U19 AI106761
6 · The paper itself

Abstract

The regulation of host-pathogen interactions during Mycobacterium tuberculosis (Mtb) infection remains unresolved. MicroRNAs (miRNAs) are important regulators of the immune system, and so we used a systems biology approach to construct an miRNA regulatory network activated in macrophages during Mtb infection. Our network comprises 77 putative miRNAs that are associated with temporal gene expression signatures in macrophages early after Mtb infection. In this study, we demonstrate a dual role for one of these regulators, miR-155. On the one hand, miR-155 maintains the survival of Mtb-infected macrophages, thereby providing a niche favoring bacterial replication; on the other hand, miR-155 promotes the survival and function of Mtb-specific T cells, enabling an effective adaptive immune response. MiR-155-induced cell survival is mediated through the SH2 domain-containing inositol 5-phosphatase 1 (SHIP1)/protein kinase B (Akt) pathway. Thus, dual regulation of the same cell survival pathway in innate and adaptive immune cells leads to vastly different outcomes with respect to bacterial containment.

Indexed as

Adaptive ImmunityAnimalsCell SurvivalCytokinesDisease Models, AnimalGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksHost-Pathogen InteractionsImmunity, InnateLymphocyte ActivationMacrophagesMiceMicroRNAsMycobacterium tuberculosisPhosphatidylinositol-3,4,5-Trisphosphate 5-PhosphatasesCytokinesInpp5d protein, mouseMicroRNAsMirn155 microRNA, mousePhosphatidylinositol-3,4,5-Trisphosphate 5-PhosphatasesProto-Oncogene Proteins c-aktmacrophagemicroRNAmiR-155Mycobacterium tuberculosisT cell

Identifiers

PMID27681624
PMCPMC5068277
OpenAlexW2526398540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.